Your browser doesn't support javascript.
loading
Long-term impact of molecular response fluctuations in chronic myeloid leukaemia patients treated with imatinib.
Molica, Matteo; Breccia, Massimo; Colafigli, Gioia; Massaro, Fulvio; Quattrocchi, Luisa; Mancini, Marco; Diverio, Daniela; Latagliata, Roberto; Foà, Robin.
  • Molica M; Department of Cellular Biotechnologies and Haematology, Sapienza University, Rome, Italy.
  • Breccia M; Department of Cellular Biotechnologies and Haematology, Sapienza University, Rome, Italy.
  • Colafigli G; Department of Cellular Biotechnologies and Haematology, Sapienza University, Rome, Italy.
  • Massaro F; Department of Cellular Biotechnologies and Haematology, Sapienza University, Rome, Italy.
  • Quattrocchi L; Department of Cellular Biotechnologies and Haematology, Sapienza University, Rome, Italy.
  • Mancini M; Department of Cellular Biotechnologies and Haematology, Sapienza University, Rome, Italy.
  • Diverio D; Department of Cellular Biotechnologies and Haematology, Sapienza University, Rome, Italy.
  • Latagliata R; Department of Cellular Biotechnologies and Haematology, Sapienza University, Rome, Italy.
  • Foà R; Department of Cellular Biotechnologies and Haematology, Sapienza University, Rome, Italy.
Br J Haematol ; 181(2): 275-278, 2018 04.
Article en En | MEDLINE | ID: mdl-28211562
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Proteínas de Fusión bcr-abl / Mesilato de Imatinib Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Proteínas de Fusión bcr-abl / Mesilato de Imatinib Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article